Loading
Total declarations
Companies
▲ Purchases (14 ops.)
▼ Sales (6 ops.)
Latest filing published 24 Jun 2026 for Centessa Pharmaceuticals plc.
Filing timeline
BuySaleMedicxi Ventures Management (Jersey) Ltd
Insider track record
Disclosed buys
14
Disclosed sells
6
Signal history
Closed purchases
Market purchases
3
Positive at T+90
0%
Median T+90
-36.2%
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -68.6%Entry US$12.36 · Close at T+365 US$3.88
- -68.6%Entry US$12.36 · Close at T+365 US$3.88
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Medicxi Ventures Management (Jersey) Ltd: trading record in brief
Medicxi Ventures Management (Jersey) Ltd is a declared insider at 2 companies; the most frequent names are Centessa Pharmaceuticals plc and Aura Biosciences, Inc. In total, 26 filings cover trades dated from 2 June 2021 to 24 June 2026.
Market trades split into 14 purchases (€20.5M) and 6 sales. The totals do not cover 6 filings with an undisclosed amount. Unlike grants, an open-market purchase is paid for by the insider, at the market price. So far in 2026, the count stands at no purchases and 6 sales.
In size, the median ticket on the buying side is €213k. Clusters matter here: 14 out of 14 purchases overlapped with buying by a colleague within 30 days. Purchases made close together by different insiders form what is called a cluster.
On 24 June 2026 came the latest disclosure, an open-market sale in Centessa Pharmaceuticals plc. The latest purchase dates back some time: it was published 1,782 days ago, on 6 December 2021. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. For comparison, the SEC allows two business days to file a Form 4. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Medicxi Ventures Management (Jersey) Ltd
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations11 total
4,398,519 sharesOrdinary SharesSEC:0001193125-26-281115:0
55,677 sharesOrdinary SharesSEC:0001193125-26-281115:1
3,936,970 sharesOrdinary SharesSEC:0001193125-26-281115:2
93,526 sharesOrdinary SharesSEC:0001193125-26-281115:3
11,197,303 sharesOrdinary SharesSEC:0001193125-26-281115:4
281,162 sharesOrdinary SharesSEC:0001193125-26-281115:5
1,794,211 shares0Ordinary SharesSEC:0000899243-22-011938:0
33,530 shares@ US$12.8243.8% of flowOrdinary SharesSEC:0000899243-21-046968:0
Canonical exit: 2 Mar 2022 (T+90)
35,992 shares@ US$11.6242.7% of flowOrdinary SharesSEC:0000899243-21-046591:0
Canonical exit: 28 Feb 2022 (T+90)
▲
Same trade as the filing by Francesco De Rubertis, counted once
130,843 USD21SEC
11,543 shares@ US$11.335313.5% of flowOrdinary SharesSEC:0000899243-21-046316:0
Canonical exit: 24 Feb 2022 (T+90)
2,275,827 sharesCommon StockSEC:0000899243-21-043033:0
1,886,990 sharesOrdinary SharesSEC:0000899243-21-022048:0
12 of 11 declarations
